Sun, May 19, 2013, 3:30 PM EDT - U.S. Markets closed
Not a bad idea. Speculation about it rises. GENE also holds a 40% stake in Immunology that deals with Immunotherapy and their recent grant of 1 million for the on/off immune system technology.